Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2024 Aug 6;150(6):e151. doi: 10.1161/CIR.0000000000001280

Correction to: ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial

PMCID: PMC12345800  PMID: 39102484

In the article by Sinha et al titled, “ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial” which published in the January 2, 2024, issue of the journal (Circulation. 2024;149:36–47. doi: 10.1161/CIRCULATIONAHA.123.066680), corrections are needed.

Two minor transcription errors occurred in Table 2. The values for peak heart rate and peak systolic blood pressure were inadvertently swapped. The values for these rows have been corrected.

In Figure 3, the P values pertaining to the ANOVA analysis for the reference group in response to ranolazine and amlodipine were also inadvertently swapped. Figure 3 has been updated.

The corrections have been made in the online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.066680.

Footnotes

Circulation is available at www.ahajournals.org/journal/circ


Articles from Circulation are provided here courtesy of Wolters Kluwer Health

RESOURCES